HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Bob Siegerink Selected Research
Bob Siegerink Research Topics
Disease
17
Ischemic Stroke
10/2022 - 11/2009
16
Stroke (Strokes)
10/2022 - 10/2015
7
Thrombosis (Thrombus)
01/2018 - 11/2009
6
Myocardial Infarction
01/2017 - 08/2009
3
Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 03/2013
3
Venous Thrombosis (Deep-Vein Thrombosis)
07/2017 - 07/2013
2
Cerebral Hemorrhage
10/2020 - 04/2016
1
Brain Ischemia (Cerebral Ischemia)
01/2021
1
Migraine Disorders (Migraine)
01/2021
1
Critical Illness (Critically Ill)
10/2020
1
Sepsis (Septicemia)
10/2020
1
Pneumonia (Pneumonitis)
10/2020
1
Atrial Fibrillation
01/2020
1
Dementia (Dementias)
01/2019
1
Out-of-Hospital Cardiac Arrest
01/2018
1
Perinatal Death
12/2017
1
Embolism (Embolus)
06/2017
1
Peripheral Arterial Occlusive Disease 1
01/2017
1
Stillbirth
01/2016
1
Edema (Dropsy)
01/2016
1
Spontaneous Abortion (Miscarriage)
01/2016
1
Leukocytosis (Pleocytosis)
01/2016
1
Thrombophilia
01/2015
1
Obesity
07/2013
1
Coronary Disease (Coronary Heart Disease)
03/2013
1
ST Elevation Myocardial Infarction
05/2011
1
Inflammation (Inflammations)
05/2011
1
Hypertension (High Blood Pressure)
11/2009
1
Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
11/2009
Drug/Important Bio-Agent (IBA)
4
Antibodies
IBA
10/2022 - 11/2009
4
Biomarkers (Surrogate Marker)
IBA
01/2020 - 06/2017
4
Oral Contraceptives
IBA
01/2016 - 11/2009
3
N-Methyl-D-Aspartate Receptors (NMDA Receptors)
IBA
10/2022 - 11/2019
3
Troponin T (Troponin T1)
IBA
01/2021 - 01/2019
3
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
03/2020 - 04/2016
3
Troponin
IBA
01/2020 - 01/2019
2
Immunoglobulin A (IgA)
IBA
10/2022 - 11/2019
2
Immunoglobulin G (IgG)
IBA
10/2022 - 11/2019
2
Immunoglobulin M (IgM)
IBA
10/2022 - 11/2019
2
fibrin fragment D (D-dimer)
IBA
01/2021 - 10/2016
2
Hemostatics (Antihemorrhagics)
IBA
01/2021 - 01/2017
2
Blood Coagulation Factors (Coagulation Factor)
IBA
12/2020 - 01/2015
2
N-Methylaspartate (NMDA)
IBA
01/2020 - 11/2019
2
Antiphospholipid Antibodies
IBA
01/2016 - 11/2009
1
Triglycerides (Triacylglycerol)
IBA
01/2022
1
Glucose (Dextrose)
FDA Link
Generic
01/2022
1
Sugars
IBA
01/2022
1
Gonadal Steroid Hormones (Sex Hormones)
IBA
01/2021
1
Fibrinogen (Factor I)
FDA Link
01/2021
1
Plasminogen Activator Inhibitor 1
IBA
01/2021
1
Smoke
IBA
01/2021
1
Factor XII (Hageman Factor)
IBA
12/2020
1
trans-crotonin (CTN)
IBA
01/2020
1
Neuroprotective Agents
IBA
11/2019
1
Protein C
IBA
01/2018
1
insulin receptor-related receptor (IRR)
IBA
12/2017
1
RNA (Ribonucleic Acid)
IBA
06/2017
1
Indicators and Reagents (Reagents)
IBA
02/2016
1
Proteins (Proteins, Gene)
FDA Link
01/2016
1
Lipoprotein(a)
IBA
10/2015
1
Lipoproteins (Lipoprotein)
IBA
10/2015
1
Biological Products
IBA
07/2013
1
symmetric dimethylarginine
IBA
03/2013
1
Antigens
IBA
02/2012
1
Sirolimus (Rapamycin)
FDA Link
05/2011
1
Lupus Coagulation Inhibitor (Lupus Anticoagulant)
IBA
11/2009
1
Factor XIII (Coagulation Factor XIII)
IBA
08/2009
Therapy/Procedure
3
Thrombectomy
01/2021 - 01/2020
1
Time-to-Treatment
01/2021
1
Critical Care (Surgical Intensive Care)
10/2020
1
Defibrillators (Defibrillator)
01/2018
1
Stents
05/2011